Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | -.--% | -.--% | -.--% |
2023 | Avivagen Inc. Announces New 500 Kg Order for OxC-beta | CI |
2023 | Avivagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-.--% | 3L | |
+16.77% | 1.2TCr | |
+3.11% | 601.29Cr | |
+4.98% | 553.64Cr | |
+14.80% | 512.43Cr | |
-20.47% | 270Cr | |
+3.80% | 196.22Cr | |
-14.27% | 126.58Cr | |
-10.05% | 96Cr | |
-18.43% | 95Cr |
- Stock Market
- Equities
- VIV Stock
- News Avivagen Inc.
- Avivagen Brief: Says Publication of Scientific Paper on Safety of Oxidized Beta Carotene is a "Milestone on the path to broader regulatory clearance to market and sell OxC-beta Products in the U.S."